Global Pharmaceuticals & Biotech Fast Growing Stocks With High Insider Ownership

Devyser Diagnostics

Market Cap: SEK 2.6b

Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.

Shanghai Rightongene Biotechnology

Market Cap: CN¥1.6b

Shanghai Rightongene Biotechnology Co., Ltd.

Caliway Biopharmaceuticals

Market Cap: NT$394.7b

Engages in the development of drugs for aesthetic medicine and chronic inflammation.

Shanghai OPM Biosciences

Market Cap: CN¥6.1b

Provides cell culture media and CDMO services in China and internationally.

Neuland Laboratories

Market Cap: ₹184.2b

Engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally.

Diamyd Medical

Market Cap: SEK 1.7b

Develops precision medicine therapies for the treatment of autoimmune diabetes.

Liquidia

Market Cap: US$2.5b

A biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States.

TriSalus Life Sciences

Market Cap: US$257.3m

Engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat liver and pancreatic cancers.

BioRestorative Therapies

Market Cap: US$13.8m

Develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells.

Oryzon Genomics

Market Cap: €204.2m

A clinical stage biopharmaceutical company, engages in the discovery and development of epigenetics-based therapeutics for patients with cancer and CNS disorders.

Krystal Biotech

Market Cap: US$4.3b

A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.

Beijing Wantai Biological Pharmacy Enterprise

Market Cap: CN¥73.1b

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

Journey Medical

Market Cap: US$187.3m

Focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.

Protalix BioTherapeutics

Market Cap: US$130.8m

A biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system.

Mendus

Market Cap: SEK 366.7m

A biopharmaceutical company, develops immunotherapies for the treatment of tumor recurrence and established tumors.

Clene

Market Cap: US$63.8m

A clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics.

Nanjing Leads Biolabs

Market Cap: HK$12.3b

A clinical-stage biotechnology company, engages in the research, development, and commercialisation of novel antibody drugs worldwide.

CanSino Biologics

Market Cap: HK$17.4b

Develops, manufactures, and commercializes vaccines in the People’s Republic of China.

InnoCare Pharma

Market Cap: HK$36.3b

A biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases in China.

Formycon

Market Cap: €409.8m

A biotechnology company, develops biosimilar drugs in Germany and Switzerland.

Harrow

Market Cap: US$1.4b

An eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products.

Aprea Therapeutics

Market Cap: US$9.1m

A clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways.

Celcuity

Market Cap: US$2.3b

A clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States.

Telix Pharmaceuticals

Market Cap: AU$4.8b

A commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals.

Inner Mongolia Furui Medical Science

Market Cap: CN¥17.3b

Inner Mongolia Furui Medical Science Co., Ltd.

Beijing Konruns PharmaceuticalLtd

Market Cap: CN¥9.3b

Engages in the research and development, production, and sale of pharmaceuticals in China and internationally.

ApicHope Pharmaceutical Group

Market Cap: CN¥32.7b

Engages in the research and development, production, and sale of pharmaceutical drugs.

Suzhou Zelgen Biopharmaceuticals

Market Cap: CN¥28.3b

Suzhou Zelgen Biopharmaceuticals Co., Ltd.

Beijing Sun-Novo Pharmaceutical Research

Market Cap: CN¥8.4b

A contract research company, engages in the research and development of drugs in China.

PYC Therapeutics

Market Cap: AU$729.1m

A drug-development company, engages in the discovery and development of novel RNA therapeutics for the treatment of genetic diseases in Australia.

Sai Life Sciences

Market Cap: ₹177.4b

Operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally.

Curaleaf Holdings

Market Cap: CA$3.1b

Produces and distributes cannabis products in the United States and internationally.

Niagen Bioscience

Market Cap: US$789.6m

Operates as a bioscience company engages in developing healthy aging products.

Shanghai Runda Medical Technology

Market Cap: CN¥10.1b

Shanghai Runda Medical Technology Co., Ltd.

Hyphens Pharma International

Market Cap: S$105.0m

Operates as a specialty pharmaceutical and consumer healthcare company primarily in Singapore, Vietnam, Malaysia, and internationally.

JBM (Healthcare)

Market Cap: HK$2.5b

An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.